CDA – Consultation on Proposed Improvements to the Reimbursement Review Process
Please visit https://www.cda-amc.ca/consultation-proposed-improvements-reimbursement-review-process for full information on this opportunity. The drug Reimbursement Review process at Canada’s Drug Agency plays a critical role in the pathway that helps patients access new drugs. In June 2023, CDA signalled program improvements that could be explored or added to the process. Since that time, (more…)








Connect With Us!